University of Calgary/Foothills Medical Centre

Calgary, Alberta T2N2T9

3 studies enrolling now · 19 studies all time

What they study most

Acute Ischemic Stroke, Acute Kidney Injury, Acute Myocardial Infarction, Acute Respiratory Distress Syndrome, Acute Spinal Cord Injury, Alzheimer's Disease, Blood Clot, Brain Injuries, Traumatic, COVID, Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage, Normal Pressure Hydrocephalus

Studies at this site

• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
• Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial — Recruiting now
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus — Running, not enrolling
• Brain Oxygen Optimization in Severe TBI, Phase 3 — Running, not enrolling
• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Running, not enrolling
• LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) — Completed
• AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke — Stopped early
• Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy — Completed
• EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Running, not enrolling
• PREVENTion of Clot in Orthopaedic Trauma — Completed
• Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke — Completed
• Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury — Stopped early
• Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy — Completed
• Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage — Completed
• Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke — Stopped early